92% of Alzheimer's cases go undiagnosed.
Hjärna changes that.
An AI-powered speech analysis platform that enables healthcare providers to detect cognitive impairment early — from the comfort of the patient's home.
The Problem
A growing crisis, hidden in plain sight.
Photography shown is for illustrative purposes only. Final assets will use approved or licensed photography.
Alzheimer's disease is the 5th leading cause of death in the US. Costs are expected to surpass $1 trillion by 2050. And the vast majority of patients who could benefit from early intervention never receive a diagnosis in time.
The Product
Passive screening. Proactive detection. Zero friction.
Outreach
Hjärna proactively contacts patients via phone-based voice AI on a configurable cadence.
Conversation
A natural, friendly conversation is recorded and securely transcribed.
Analysis
Our models analyse speech patterns for early markers of cognitive change.
"Hjärna meets patients where they are — at home, in their own voice, on their own time."
Designed for Home Use
Patients are screened from their own environment — no clinic visit required.
Provider Dashboard
Insights integrate cleanly into existing clinical workflows.
Scalable at Population Level
Built for health systems, not individual clinics.
HIPAA & GDPR Compliant
Engineered for regulated healthcare environments from day one.
For Providers
Built for healthcare systems.
Hjärna slots into the workflows your clinicians already use — surfacing risk signals without adding to their workload.
- EHR integration ready
- Automated patient outreach
- Configurable screening frequency
- Clinician alert system
- Reporting & analytics
- Multilingual capability (coming soon)
Clinical Evidence
Built on peer-reviewed research.
"Early pilot demonstrated promising sensitivity in detecting MCI versus standard screening protocols."
Internal pilot — full results pending publication
An estimated 7.4 million Medicare beneficiaries are living with undiagnosed mild cognitive impairment.
Alzheimer's Research & Therapy
Who we serve
Designed for the moments that matter.
Primary Care Providers
Routine cognitive screening at scale, without adding clinical burden.
Routine cognitive screening for hundreds of patients — without adding clinical burden.
Health Insurers
Proactive risk management for ageing populations.
Proactive risk identification before costly late-stage interventions.
Longevity & Memory Clinics
Specialist-grade early detection, integrated into your care pathway.
Specialist-grade early detection, seamlessly integrated into your care pathway.
The Team
The team behind Hjärna.
Scientific Advisory Board
Names coming soon.
Backed by science. Built for scale.
Investors & Partners
We're actively seeking strategic partners and early investment.
Hjärna is currently in active pilot discussions with healthcare systems and open to strategic investment. If you represent a health system, insurer, or investor aligned with our mission, we'd like to speak with you.
Ready to bring early detection to your patients?
Book a 30-minute demo. We'll show you exactly how Hjärna fits into your existing workflows.